Our 2024/2025 ESG report marks a year of progress
We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.
24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
We are pleased to announce the release of our ESG report for 2024/2025, which describes our collective progress across environmental sustainability, social responsibility and ethical governance.
Bold Ideas, Bright Futures: Brilliance in Medical Affairs was the theme of this year’s joint Medical Affairs Professionals of Australasia (MAPA) and Medical Affairs Professional Society (MAPS) Australasia Medical Affairs Summit. The 2-day meeting was held on 24 and 25 September in Sydney, Australia, and welcomed over 300 attendees and 75 faculty members.
On Monday 8 September, Oxford PharmaGenesis enjoyed an evening of inspiration, connection and impact at the prestigious Friends of the National Library of Medicine (NLM) Gala 2025. Guests gathered at the Willard InterContinental Hotel, Washington DC, to celebrate leaders who are making a difference in health information, public service and community engagement. Awardees included…
A vast amount of valuable clinical trial information exists in the world but much of it is fragmented, hard to verify and difficult to use, slowing medical research and patient care. This lack of connectivity delays research, complicates evidence synthesis, and limits the ability of healthcare professionals, patients and other stakeholders to access clear, reliable information.
To address these challenges, Trace Labs, the core developers of OriginTrail, and Oxford PharmaGenesis have partnered on a groundbreaking initiative to globally connect and verify medical knowledge.
Over the past two months, we’ve had the privilege of engaging with the healthcare communications and patient engagement communities at MAPS EMEA, ISMPP Annual, ISPOR US and Patients as Partners Europe. Across continents and conversations, one theme clearly stood out: patient involvement is no longer optional – it is essential.
Multiple Sclerosis Awareness Week – shining a light on unmet needs Vast strides have been made in multiple sclerosis (MS) treatment and care in recent years. Despite these advancements, unmet needs remain for people living with this lifelong condition that can severely impact many aspects of their lives. MS Brain Health – time matters 2024,…